Philip Watson Mb Msc Frcp Ffpm

Philip Watson MB MSc FRCP FFPM is an accomplished executive in the pharmaceutical industry with extensive experience in drug safety and risk management. Currently serving as Executive Director at BeiGene since April 2019, Philip previously held leadership roles at Mediacta PV Ltd, Boehringer Ingelheim, Novartis Pharma AG, and Roche Products Ltd, with a focus on safety operations and brand leadership in major pharmacological projects. Philip's early career included significant positions at Alleyn Healthcare Consulting, Exprimo Consulting, Pharsight Corporation, and SmithKline Beecham P., demonstrating a strong foundation in healthcare consultancy and business development. Philip Watson's academic background includes an MBBS in Medicine from St Mary's Hospital Medical School at Imperial College, London.